Testing effectiveness (Phase 2)Looking for participantsNCT05508347
What this trial is testing
Nituzumab (Taixinsheng ®) A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 170